ArticleCarcinogenesis2021

LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma.

Yasuyuki Okada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.